ClinConnect ClinConnect Logo
Search / Trial NCT06547632

ClearPetra™ Vacuum-assisted Ureteral Access Sheath Vs Traditional Approach

Launched by UNIVERSITY OF KANSAS MEDICAL CENTER · Aug 7, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Nephrolithiasis Kidney Stone Clear Petra Ureteral Access Sheath

ClinConnect Summary

This clinical trial is looking at a new device called ClearPetra™, which is a vacuum-assisted ureteral access sheath used during a procedure to remove kidney stones. The trial aims to compare how well this new device works against traditional methods (which might not use a sheath or use a non-vacuum sheath) in helping to clear kidney stones and reduce the chances of infection after the procedure. Ureteroscopy, the procedure being studied, is typically recommended for treating kidney stones that are smaller than 2 centimeters.

To participate in this trial, you need to be at least 18 years old and scheduled for a specific type of surgery to remove kidney stones that are between 1.0 and 2.5 centimeters in size. However, there are some people who cannot join, such as those with certain medical conditions or who are pregnant. If you are eligible and choose to participate, you can expect to help researchers understand how effective the ClearPetra device is, which could lead to better treatment options for kidney stones in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Males or females over18 years of age
  • 2. Undergoing primary flexible ureteroscopy for retrograde intrarenal surgery
  • 3. Total stone burden between 1.0 to 2.5 cm
  • Exclusion Criteria:
  • 1. Undergoing bilateral stone treatment during the same procedure
  • 2. Patients with known genitourinary anatomical abnormalities
  • 3. Uncorrected coagulopathy
  • 4. Patients with urinary diversions
  • 5. Chronic external urinary catheters
  • 6. Women who are pregnant
  • 7. Immunosuppressed patients
  • 8. Non-elective procedures

About University Of Kansas Medical Center

The University of Kansas Medical Center (KUMC) is a leading academic medical institution dedicated to advancing healthcare through innovative research, education, and clinical practice. As a prominent clinical trial sponsor, KUMC leverages its extensive expertise in diverse medical fields to conduct rigorous clinical research aimed at improving patient outcomes and developing new treatment modalities. With a commitment to ethical standards and patient safety, KUMC collaborates with multidisciplinary teams to facilitate groundbreaking studies that address significant health challenges, ultimately contributing to the advancement of medical knowledge and the enhancement of community health.

Locations

Kansas City, Kansas, United States

Patients applied

0 patients applied

Trial Officials

Wilson Molina, MD

Principal Investigator

Study Principal Investigator

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported